Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2025 Mar 10;12(3):97.
doi: 10.3390/jcdd12030097.

Hemodynamic Effects of Positive Airway Pressure: A Cardiologist's Overview

Anna Di Cristo  1   2 , Andrea Segreti  1   2   3 , Nardi Tetaj  1   2 , Simone Pasquale Crispino  1   2 , Emiliano Guerra  4 , Emanuele Stirpe  5 , Gian Paolo Ussia  1   2 , Francesco Grigioni  1   2
Affiliations
Review

Hemodynamic Effects of Positive Airway Pressure: A Cardiologist's Overview

Anna Di Cristo et al. J Cardiovasc Dev Dis. .

Abstract

Positive airway pressure (PAP) therapy is widely used to manage both acute and chronic respiratory failure and plays an increasingly important role in cardiology, particularly in treating patients with respiratory comorbidities. PAP, including continuous positive airway pressure and noninvasive ventilation, significantly impacts hemodynamics by altering intrathoracic pressure, affecting preload, afterload, and stroke volume. These changes are crucial in conditions such as acute cardiogenic pulmonary edema, where PAP can enhance gas exchange, reduce the work of breathing, and improve cardiac output. PAP reduces the left ventricular afterload, which in turn increases stroke volume and myocardial contractility in patients with left-sided heart failure. However, the role of PAP in right ventricular function and its effects on venous return and cardiac output are critical in the cardiac intensive care setting. While PAP provides respiratory benefits, it must be used cautiously in patients with right heart failure or preload-dependent conditions to avoid adverse outcomes. Additionally, in recent years, the use of PAP has expanded in the treatment of severe obstructive sleep apnea and obesity hypoventilation syndrome, both of which significantly influence cardiovascular events and heart failure. This review provides an in-depth analysis of the hemodynamic effects of PAP in cardiovascular disease, focusing on its impact on ventricular function in both acute and chronic conditions. Evaluating clinical studies, guidelines, and recent advancements offers practical insights into the physiological mechanisms and key clinical considerations. Furthermore, this review aims to serve as a helpful guide for clinicians, assisting in decision-making processes where PAP therapy is applied.

Keywords: acute respiratory failure (ARF); bilevel positive airway pressure (BiPAP); cardiogenic pulmonary edema (CPE); continuous positive airway pressure (CPAP); non-invasive ventilation (NIV); obesity hypoventilation syndrome (OHS); obstructive sleep apnea (OSA); positive airway pressure (PAP).

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Pulmonary and hemodynamic effects of positive airway pressure (PAP). RV: right ventricle; LV: left ventricle, upward arrow indicates an increase, downward arrows indicate a decrease.
Figure 2
Figure 2
(A) Effects of PAP in ACPE. (B) Effects of PAP on left chambers and right chambers. ACPE: acute cardiogenic pulmonary edema; LV: left ventricle; PAP: positive airway pressure; PTm: transmural pressure; PtP: transpulmonary pressure; RA: right atrium; RV: right ventricle; SV: stroke volume; upward arrows indicate an increase; downward arrows indicate a decrease.
Figure 3
Figure 3
Complications of positive airway pressure (PAP).
Figure 4
Figure 4
Example of the algorithm for oxygen support in patients with acute respiratory failure. ARF: acute respiratory failure; HFNO: high-flow nasal oxygen; CPAP: continuous positive airway pressure; BiPAP: bilevel positive airway pressure; PEEP: positive end-expiratory pressure; COPD, chronic obstructive pulmonary disease.
See this image and copyright information in PMC

References

    1. Sinha S.S., Sjoding M.W., Sukul D., Prescott H.C., Iwashyna T.J., Gurm H.S., Cooke C.R., Nallamothu B.K. Changes in Primary Noncardiac Diagnoses Over Time Among Elderly Cardiac Intensive Care Unit Patients in the United States. Circ. Cardiovasc. Qual. Outcomes. 2017;10:e003616. doi: 10.1161/CIRCOUTCOMES.117.003616. - DOI - PMC - PubMed
    1. Metkus T., Miller P.E., Alviar C.L., Jentzer J.C., van Diepen S., Katz J.N., A Morrow D., Schulman S., Eid S. Incidence, predictors and prognosis of respiratory support in non-ST segment elevation myocardial infarction. Eur. Heart J. Acute Cardiovasc. Care. 2020;10:200–206. doi: 10.1177/2048872620919947. - DOI - PubMed
    1. Morrow D.A. Trends in Cardiac Critical Care: Reshaping the Cardiac Intensive Care Unit. Circ. Cardiovasc. Qual. Outcomes. 2017;10:e004010. doi: 10.1161/CIRCOUTCOMES.117.004010. - DOI - PubMed
    1. Morrow D.A., Fang J.C., Fintel D.J., Granger C.B., Katz J.N., Kushner F.G., Kuvin J.T., Lopez-Sendon J., McAreavey D., Nallamothu B., et al. Evolution of Critical Care Cardiology: Transformation of the Cardiovascular Intensive Care Unit and the Emerging Need for New Medical Staffing and Training Models: A Scientific Statement From the American Heart Association. Circulation. 2012;126:1408–1428. doi: 10.1161/CIR.0b013e31826890b0. - DOI - PubMed
    1. McDonagh T.A., Metra M., Adamo M., Gardner R.S., Baumbach A., Böhm M., Burri H., Butler J., Čelutkienė J., Chioncel O., et al. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur. Heart J. 2021;42:3599–3726. doi: 10.1093/eurheartj/ehab368. - DOI - PubMed

LinkOut - more resources